An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemia.
暂无分享,去创建一个
N. Stergiopulos | F. Mach | R. Fraga-Silva | F. D. de Sousa | F. Montecucco | R. Sinisterra | Robson A. S. Santos | R. D. da Silva | S. Savergnini | F. Costa-Fraga | Daniele Caetano da Silva | Robson A. S. Santos | Fabiana P Costa-Fraga | Silvia Q Savergnini | Ruben D Sinisterra
[1] A. Burnett,et al. Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis. , 2012, The journal of sexual medicine.
[2] A. Ferreira,et al. Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats , 2012, International journal of hypertension.
[3] P. Gallagher,et al. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1. , 2012, American journal of physiology. Heart and circulatory physiology.
[4] M. Raizada,et al. New Cardiovascular and Pulmonary Therapeutic Strategies Based on the Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas Receptor Axis , 2012, International journal of hypertension.
[5] G. Brock,et al. Investigative models in erectile dysfunction: a state-of-the-art review of current animal models. , 2011, The journal of sexual medicine.
[6] R. Webb,et al. Increased cavernosal relaxation by Phoneutria nigriventer toxin, PnTx2-6, via activation at NO/cGMP signaling , 2011, International Journal of Impotence Research.
[7] S. Suresh,et al. Effect of Mucuna pruriens (Linn.) on oxidative stress-induced structural alteration of corpus cavernosum in streptozotocin-induced diabetic rat. , 2011, The journal of sexual medicine.
[8] M. Böhm,et al. Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol‐induced atherosclerosis , 2011, British journal of pharmacology.
[9] N. Alenina,et al. An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect , 2011, Clinics.
[10] A. Ferreira,et al. An Oral Formulation of Angiotensin-(1-7) Produces Cardioprotective Effects in Infarcted and Isoproterenol-Treated Rats , 2011, Hypertension.
[11] M. Raizada,et al. Angiotensin‐converting enzyme 2 activation protects against hypertension‐induced cardiac fibrosis involving extracellular signal‐regulated kinases , 2011, Experimental physiology.
[12] N. Alenina,et al. ACE2–angiotensin-(1–7)–Mas axis and oxidative stress in cardiovascular disease , 2011, Hypertension Research.
[13] Jun Ren,et al. Angiotensin-(1-7) ameliorates myocardial remodeling and interstitial fibrosis in spontaneous hypertension: role of MMPs/TIMPs. , 2010, Toxicology letters.
[14] M. Raizada,et al. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. , 2010, American journal of respiratory and critical care medicine.
[15] A. Burnett,et al. Hypercholesterolemia-induced erectile dysfunction: endothelial nitric oxide synthase (eNOS) uncoupling in the mouse penis by NAD(P)H oxidase. , 2010, The journal of sexual medicine.
[16] W. Border,et al. Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. , 2010, American journal of physiology. Renal physiology.
[17] M. Raizada,et al. Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. , 2010, Hypertension.
[18] K. Sharma,et al. Mechanisms of kidney fibrosis and the role of antifibrotic therapies , 2009, Current opinion in nephrology and hypertension.
[19] U. Laufs,et al. Improvement of Endothelial Function of the Corpus Cavernosum in Apolipoprotein E Knockout Mice Treated with Irbesartan , 2008, Journal of Pharmacology and Experimental Therapeutics.
[20] M. Raizada,et al. Angiotensin-(1-7) as an antihypertensive, antifibrotic target , 2008, Current hypertension reports.
[21] D. Ganten,et al. Update on tissue renin–angiotensin systems , 2008, Journal of Molecular Medicine.
[22] F. Luft,et al. Endothelial Dysfunction and Elevated Blood Pressure in Mas Gene-Deleted Mice , 2008, Hypertension.
[23] H. A. Duarte,et al. Study of angiotensin-(1–7) vasoactive peptide and its β-cyclodextrin inclusion complexes: Complete sequence-specific NMR assignments and structural studies , 2007, Peptides.
[24] R. Touyz,et al. Evidence that the vasodilator angiotensin-(1-7)-Mas axis plays an important role in erectile function. , 2007, American journal of physiology. Heart and circulatory physiology.
[25] I. Benter,et al. Different responses to angiotensin-(1-7) in young, aged and diabetic rabbit corpus cavernosum. , 2007, Pharmacological research.
[26] B. Annex,et al. A mouse model of hypercholesterolemia-induced erectile dysfunction. , 2007, The journal of sexual medicine.
[27] M. Teixeira,et al. The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of Angiotensin-(1-7). , 2007, Journal of hepatology.
[28] J. Grobe,et al. Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. , 2006, American journal of physiology. Heart and circulatory physiology.
[29] T. Lue,et al. Physiology of penile erection and pathophysiology of erectile dysfunction. , 2005, The Urologic clinics of North America.
[30] R. A. Santos,et al. Cardiovascular actions of angiotensin-(1-7). , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[31] K. Uekama,et al. Design and evaluation of cyclodextrin-based drug formulation. , 2004, Chemical & pharmaceutical bulletin.
[32] R. Touyz. Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[33] W. Hellstrom,et al. Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. , 2003, Journal of andrology.
[34] U. Jonas,et al. Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. , 2001, Urology.
[35] Ç. Yeşilli,et al. Effect of experimental hypercholesterolemia on cavernosal structures. , 2001, Urology.
[36] A. Nishiyama,et al. Systemic and Regional Hemodynamic Responses to Tempol in Angiotensin II–Infused Hypertensive Rats , 2001, Hypertension.
[37] D. Ganten,et al. Converting enzyme determines plasma clearance of angiotensin-(1-7). , 1998, Hypertension.
[38] D. Udelson,et al. Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. , 1998, The Journal of urology.
[39] K. Cho,et al. Renin angiotensin system in rabbit corpus cavernosum: functional characterization of angiotensin II receptors. , 1997, The Journal of urology.
[40] R. Dluhy,et al. Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum. , 1997, The Journal of urology.
[41] S. Snyder,et al. Nitric oxide: a physiologic mediator of penile erection. , 1992, Science.
[42] K. Azadzoi,et al. Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. , 1991, The Journal of urology.
[43] S. Wilson,et al. Role of oxygen-derived free radicals in acute angiotensin II--induced hypertensive vascular disease in the rat. , 1990, Circulation research.
[44] K. Baek,et al. Involvement of superoxide radical in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbits , 2004, Urological Research.
[45] U. Jonas,et al. Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence. , 2001, Urology.
[46] M. Davies,et al. Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction. , 1994, The Journal of urology.